New shoulder implant shows promise for arthritis patients

NCT ID NCT02405208

Completed Disease control Sponsor: Smith & Nephew, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new shoulder implant called PyroTITAN HRA in 156 people with arthritis. The implant resurfaces the ball part of the shoulder joint to relieve pain and improve function. Researchers tracked how long the device lasted and whether it caused problems, aiming to see if it's a good option for shoulder arthritis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PyroTITAN HRA shoulder implant (a device that resurfaces the humeral head of the shoulder joint)
What this could lead to: If successful, this implant could provide a durable option for shoulder arthritis patients, potentially delaying or avoiding the need for a full shoulder replacement.
What could go wrong: This is a completed study with 156 participants, but it was not randomized or blinded, so results may be less reliable. The implant may fail over time, requiring additional surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arthritic joint disease osteoarthritis rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARTHRITIS

Contacts and locations

Locations

Barwon Health

Geelong, Victoria, 3220, Australia
Brisbane Hand & Upper Limb Clinic

Brisbane, Queensland, 4001, Australia
Danderyd Hospital

Stockholm, S-182 88, Sweden
Institut Nices

Nice, 06000, France
Wrightington Hospital

Wigan, Wrightington, WN6 9EP, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.